Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxamic acid is a small molecule and the monoamide derivative of oxalic acid with the chemical formula C₂H₃NO₃. It is a white, water-soluble solid used primarily in research settings. Oxamic acid acts as an inhibitor of lactate dehydrogenase A (LDHA), binding to the LDH-NADH complex and blocking its active site. This inhibition disrupts glycolysis by preventing the conversion of pyruvate to lactate in highly glycolytic cells[4]. Additionally, it serves as a precursor for carbamoyl radical generation in organic synthesis and has applications in polymer chemistry to increase water solubility of certain polymers[6]. Oxamic Acid is not approved for clinical use but is widely used experimentally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxamic acid.